In a human crossover study, 30-day supplementation with resveratrol decreased ACE2 in adipose tissue [216], potentially attenuating an increased risk for infection and viral replication in humans with obesity. This evidence concerns the gene ACE2 and obesity due to melanocortin 4 receptor deficiency.